IL17A and colitis: IL-17RA (–/–) mice have been shown to be less susceptible to acute intestinal mucosal injury [27], and IL-17 (–/–) or the application of an anti-IL-17 antibody can alleviate TNBS induced experimental colitis in mice [28].